TY - JOUR
T1 - Corrigendum to “Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)” [The Lancet Regional Health – Europe 40 (2024) 100892] (The Lancet Regional Health - Europe (2024) 40, (S2666776224000589), (10.1016/j.lanepe.2024.100892))
AU - Leruez-Ville, Marianne
AU - Chatzakis, Christos
AU - Lilleri, Daniele
AU - Blazquez-Gamero, Daniel
AU - Alarcon, Ana
AU - Bourgon, Nicolas
AU - Foulon, Ina
AU - Fourgeaud, Jacques
AU - Gonce, Anna
AU - Jones, Christine E.
AU - Klapper, Paul
AU - Krom, André
AU - Lazzarotto, Tiziana
AU - Lyall, Hermione
AU - Paixao, Paulo
AU - Papaevangelou, Vassiliki
AU - Puchhammer, Elisabeth
AU - Sourvinos, George
AU - Vallely, Pamela
AU - Ville, Yves
AU - Vossen, Ann
N1 - Funding Information:
MLV reports receiving support for attending meetings by BioM\u00E9rieux and Altona outside the submitted work. MLV reports payment made to her institution for presentation/lecture by Diasorin, Abbott Molecular and Roche Diagnostic outside the submitted work. DBG received Grant from the Spanish Ministry of Science and Innovation. ISCIII and Fondos FEDER (EU) outside the submitted work and received Honoraria for lectures from the Medscape, outside the submitted work. JF received honoraria for poster presentation by Abbott GmbH, outside the submitted work. CJ received consulting fees from Moderna, outside the submitted work; Participated on a Data Safety Monitoring Board or Advisory Board of Moderna, outside the submitted work; Is Co-director of the European Congenital CMV Initiative; Her institution received payment for clinical trials by Moderna, outside the submitted work. HL participated on advisory board for the Study of Zidovudine in children with Aicadri-Goutiere Syndrome, outside the submitted work and she is Trustee of European Society For Paediatric Infectious Diseases (ESPID). VP institution received honoraria for lectures from MSD and Pfizer, outside the submitted work and received support for attending a meeting (ESPID 2023) from Pfizer. PV is president and board-member of the European Congenital CMV Initiative. AV is participating in the Advisory Council European Society of Virology. The rest author of the authors declare no conflict of interest.
Publisher Copyright:
© 2024 The Author(s)
PY - 2024/7
Y1 - 2024/7
N2 - The authors have noticed an error in the title where it should read “European congenital cytomegalovirus initiative (ECCI)” instead of “European congenital infection initiative (ECCI)”. The authors would like to apologise for any inconvenience caused.
AB - The authors have noticed an error in the title where it should read “European congenital cytomegalovirus initiative (ECCI)” instead of “European congenital infection initiative (ECCI)”. The authors would like to apologise for any inconvenience caused.
UR - http://www.scopus.com/inward/record.url?scp=85196305596&partnerID=8YFLogxK
U2 - 10.1016/j.lanepe.2024.100974
DO - 10.1016/j.lanepe.2024.100974
M3 - Comment/debate
C2 - 39050231
AN - SCOPUS:85196305596
SN - 2666-7762
VL - 42
JO - The Lancet Regional Health - Europe
JF - The Lancet Regional Health - Europe
M1 - 100974
ER -
